Collectively, targeting ubiquitination pathways (BIM stabilization, Cbl-mediated c-KIT degradation, and GPX4-driven ferroptosis) reveals promising therapeutic strategies against GIST. The gene discussed is BCL2L11; the disease is gastrointestinal stromal tumor.